NCT04198493

Brief Summary

Adults with Down syndrome (DS) have a high prevalence of obstructive sleep apnea (OSA), which may worsen cognitive performance. In general population, continuous positive airway pressure (CPAP), the gold Standard treatment for OSA, partially reverses cognitive impairment secondary to OSA. CPAP treatment, however, is not regularly proposed in adults with DS and OSA. It is usually presumed both by caregivers and physicians, that DS patients will not tolerate or adapt to the treatment, and that they would not benefit much more from CPAP treatment. Therefore, data about the feasibility and impact of CPAP treatment on cognitive function in this population is lacking. The main objective of this study is to investigate cognitive performance in adults with DS and OSA, the corresponding functional brain changes and their reversibility with CPAP treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 28, 2019

Completed
3 days until next milestone

Study Start

First participant enrolled

December 1, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 13, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

December 17, 2019

Status Verified

December 1, 2019

Enrollment Period

11 months

First QC Date

November 28, 2019

Last Update Submit

December 13, 2019

Conditions

Keywords

Down SyndromePolysomnography

Outcome Measures

Primary Outcomes (2)

  • Assessment of the changes on cognitive attentional tasks

    psychomotor speed (in seconds) performing an attentional task

    Baseline and after 6 months of treatment

  • Changes in cerebral functional connectivity

    Significant probability maps (SPM) showing statistical changes on connectivity measures between sleep stages

    Baseline and after 6 months of treatment

Study Arms (2)

Continuous Positive Airway Pressure(CPAP)

EXPERIMENTAL

Patients with CPAP treatment. Titration will be performed by polysomnography CPAP to determine the optimal treatment pressure. This group will also be instructed in sleep hygiene and dietary counseling Intervention: Device: CPAP Other: Conservative treatment for OSA

Device: CPAPOther: CONSERVATIVE TREATMENT for OSA

CONSERVATIVE TREATMENT for OSA

ACTIVE COMPARATOR

Sleep hygiene and dietary counseling. Sleep hygiene (regular sleep schedule, physical exercise) and dietary counseling Intervention: Other: Conservative treatment for OSA

Other: CONSERVATIVE TREATMENT for OSA

Interventions

CPAPDEVICE

CPAP treatment every night plus conservative treatment for OSA: sleep hygiene and dietary counseling

Continuous Positive Airway Pressure(CPAP)

Conservative treatment for OSA: sleep hygiene and dietary counseling

CONSERVATIVE TREATMENT for OSAContinuous Positive Airway Pressure(CPAP)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects of both sexes with ages over 18 years old with DS.
  • A good general health with adequate visual and auditory acuity will be required
  • Understanding and accepting the study procedures and signing an informed consent (guardian and / or patient).
  • intelligence quotient(IQ) ratio\> 34 (mild and moderate severe intellectual disability according to the International Statistical Classification of Diseases and Related Health Problems, ICD-10, criteria).
  • Subjects without dementia: Absence of loss of cognitive functions (demonstrated by the longitudinal administration of neuropsychological tests and verified by family members)
  • Absence of psychiatric comorbidity

You may not qualify if:

  • Severe intellectual disability (due to limitations in cognitive tests)
  • Presence of psychiatric pathology, unstable disease, cardiac or respiratory failure.
  • Intake of psychoactive drugs in the three months prior to the study.
  • Patients diagnosed with OSA, undergoing treatment with CPAP.
  • Subjects with an Epworth Sleep Scale score \> 12

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Multidisciplinary Sleep Unit. Hospital de la Santa Creu i Sant Pau

Barcelona, 08025, Spain

Location

MeSH Terms

Conditions

Sleep Apnea, ObstructiveDown Syndrome

Interventions

Conservative Treatment

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesIntellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesChromosome DisordersGenetic Diseases, Inborn

Intervention Hierarchy (Ancestors)

Therapeutics

Central Study Contacts

SANDRA GIMENEZ BADIA, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Open pilot study with randomized therapeutic intervention of parallel groups and blind evaluation in neuropsychological assessment.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2019

First Posted

December 13, 2019

Study Start

December 1, 2019

Primary Completion

November 1, 2020

Study Completion

November 1, 2021

Last Updated

December 17, 2019

Record last verified: 2019-12

Locations